These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8792397)

  • 21. Anemia of renal failure. Use of erythropoietin.
    Humphries JE
    Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of chemotherapy-induced anemia by the use of erythropoietin in patients with primary malignant bone tumors (a double-blind, randomized, phase III study).
    Wurnig C; Windhager R; Schwameis E; Kotz R; Zoubek A; Stockenhuber F; Kurz RW
    Transfusion; 1996 Feb; 36(2):155-9. PubMed ID: 8614967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythropoietin treatment in children with renal failure.
    Van Damme-Lombaerts R; Herman J
    Pediatr Nephrol; 1999 Feb; 13(2):148-52. PubMed ID: 10229005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possible role of soluble erythropoietin receptors in renal anemia].
    Sakaguchi M; Maeda Y; Naiki Y; Hasegawa H; Kanamaru A
    Nihon Jinzo Gakkai Shi; 2002 Oct; 44(7):524-9. PubMed ID: 12476588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP).
    Macdougall IC
    Nephrol Dial Transplant; 2001; 16 Suppl 3():14-21. PubMed ID: 11402086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant human erythropoietin in cancer-related anemia. Review of clinical evidence.
    Crawford J
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):41-53. PubMed ID: 12380954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease.
    Nissenson AR
    Am J Kidney Dis; 2001 Dec; 38(6):1390-7. PubMed ID: 11728981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of oxymetholone in combination with erythropoietin on hematologic parameters and muscle mass in CAPD patients.
    Aramwit P; Palapinyo S; Wiwatniwong S; Supasyndh O
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):803-13. PubMed ID: 21084036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
    Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
    Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous erythropoietin (rHuEPO) administration increases plasma endothelin and blood pressure in hemodialysis patients.
    Carlini R; Obialo CI; Rothstein M
    Am J Hypertens; 1993 Feb; 6(2):103-7. PubMed ID: 8471228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients.
    Malgorzewicz S; Lichodziejewska-Niemierko M; Lizakowski S; Liberek T; Lysiak-Szydlowska W; Rutkowski B
    Clin Nephrol; 2010 Mar; 73(3):210-5. PubMed ID: 20178720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain after subcutaneous injection of recombinant human erythropoietin: does Emla cream help?
    Morris KP; Hughes C; Hardy SP; Matthews JN; Coulthard MG
    Nephrol Dial Transplant; 1994; 9(9):1299-301. PubMed ID: 7816294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous recombinant human erythropoietin in chronic renal allograft dysfunction.
    Aufricht C; Marik JL; Ettenger RB
    Pediatr Nephrol; 1998 Jan; 12(1):10-3. PubMed ID: 9502558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human erythropoietin treatment of anemia in renal transplant patients.
    Lezaic V; Djukanovic L; Pavlovic-Kentera V
    Ren Fail; 1995 Nov; 17(6):705-14. PubMed ID: 8771243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human erythropoietin use in intensive care.
    Darveau M; Notebaert E; Denault AY; Bélisle S
    Ann Pharmacother; 2002 Jun; 36(6):1068-74. PubMed ID: 12022910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaemia of critical illness-- implications for understanding and treating rHuEPO resistance.
    Eckardt KU
    Nephrol Dial Transplant; 2002; 17 Suppl 5():48-55. PubMed ID: 12091608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythropoietin associated hypertension among pediatric dialysis patients.
    Komatsu Y; Ito K
    Adv Perit Dial; 1992; 8():448-52. PubMed ID: 1361845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.